X.T.L. Biopharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NOKED ISRAEL LTD | 02/13/2026 | 198.89 K | $115.00 K | 0.00% | 11.82% |
| CITADEL ADVISORS LLC | 02/17/2026 | 75.87 K | $44.00 K | 100.00% | 4.51% |
| RHUMBLINE ADVISERS | 02/13/2026 | 30.11 K | $17.46 K | 74.43% | 1.79% |
| GAMMA INVESTING LLC | 01/05/2026 | 12.89 K | $7.47 K | 100.00% | 0.77% |
| XTX TOPCO LTD | 02/17/2026 | 10.24 K | $5.94 K | 100.00% | 0.61% |
| MORGAN STANLEY | 02/13/2026 | 1.74 K | $1.01 K | -82.62% | 0.10% |
| UBS GROUP AG | 01/29/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
X.T.L. Biopharmaceuticals Ltd. institutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of X.T.L. Biopharmaceuticals Ltd.. The most heavily invested institutionals were:
GAMMA Investing LLC: 0
Noked Israel Ltd: 198,888
CITADEL ADVISORS LLC: 75,866
RHUMBLINE ADVISERS: 30,108
XTX Topco Ltd: 10,238
MORGAN STANLEY: 1,740
19.60% of X.T.L. Biopharmaceuticals Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 515.73 K shares in the last 24 months. This purchase volume represents approximately $361.01 K in transactions.